Despite the brand name "DIAMPA" (commonly associated with dapagliflozin in Pakistan), the formulation "12.5+850mg" does NOT contain dapagliflozin. This is because:

1. ✅ Dapagliflozin is only approved in 5mg and 10mg doses globally.
2. ❌ 12.5mg is not a valid dose for dapagliflozin—such a strength does not exist.

In Pakistan, the notation "12.5+850" follows a standard local naming convention for antidiabetic fixed-dose combinations, where:

"12.5" = Glimepiride 2mg

"850" = Metformin 850mg

This coding arises from informal shorthand (e.g., “2” + “85” ≈ “12.5”), widely used by pharmaceutical companies across Pakistan—even when using brand names typically linked to newer drugs like SGLT2 inhibitors.

Confirmed Likely Composition:

✅ Active Ingredients:

1. Glimepiride 2mg
2. Metformin Hydrochloride 850mg

This is a well-established, high-efficacy dual-combination therapy for type 2 diabetes mellitus.

Product Full Description (English):

Uses:

1. Treatment of type 2 diabetes in adults inadequately controlled with diet, exercise, or monotherapy
2. Simplified dual therapy to improve adherence and glycemic control

Key Benefits:

1. Glimepiride: Stimulates insulin secretion from pancreatic beta cells
2. Metformin 850mg: Reduces hepatic glucose production and improves insulin sensitivity
3. Intermediate-to-high metformin dose balances efficacy and tolerability
4. Cost-effective and widely accessible regimen

How To Use:

Take once or twice daily with meals (typically breakfast and/or dinner) to reduce hypoglycemia risk. Swallow whole with water—do not crush or chew.

When Not to Use:

1. Type 1 diabetes or diabetic ketoacidosis
2. Severe renal impairment (eGFR <30 mL/min)
3. Hypersensitivity to sulfonylureas or metformin
4. Acute alcohol intoxication, liver disease, or metabolic acidosis

Side Effects:

1. Common: Hypoglycemia (sweating, tremor, dizziness, hunger), nausea, diarrhea, metallic taste
2. Serious (rare): Lactic acidosis (muscle pain, weakness, rapid breathing), severe hypoglycemia, liver dysfunction

Dosage:

1. Typical dose: 1 tablet once or twice daily with meals
2. Maximum glimepiride: usually 4–6mg/day (i.e., up to 2–3 tablets)
3. Adjust based on blood glucose and HbA1c monitoring

Warnings & Precautions:

1. Hypoglycemia risk increases with skipped meals, excessive exercise, or alcohol
2. Avoid alcohol—raises risk of lactic acidosis and low blood sugar
3. Discontinue before iodinated contrast imaging or major surgery
4. Monitor kidney function and HbA1c regularly

Drug Interactions:

1. Alcohol: ↑ Risk of lactic acidosis and hypoglycemia
2. Beta-blockers: May mask hypoglycemia symptoms (e.g., tachycardia)
3. NSAIDs, sulfonamides, warfarin: May enhance glimepiride effect → hypoglycemia
4. Cimetidine: May increase metformin levels

Critical Recommendation:

🔍 Always verify the active ingredients printed on the packaging.

1. If it lists "Glimepiride 2mg + Metformin 850mg", this description applies.
2. If it claims "Dapagliflozin 12.5mg", it is incorrect labeling—do not use.

In Pakistan,